ArticleCell transplantation

A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial.

Qiaomei He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.